The FCS Foundation is overjoyed with the news that the FDA has approved the first treatment for patients with Familial Chylomicronemia Syndrome. The last few years have been a roller coaster for our community and we are so happy that our patients will finally get the treatment they deserve. Thank you to our patients who shared their very vulnerable stories, our industry partners who tirelessly campaigned for research and treatment options, our senators and congressmen who supported the The Heart Act, and our family, friends and caregivers who always cheered us on.
BREAKING NEWS: We’re thrilled to share we have received U.S. FDA approval for TRYNGOLZA? (olezarsen), cementing Ionis as a fully integrated commercial-stage biotech company. Read more: https://lnkd.in/eg2G4NpH